AKT Isoforms Interplay in High-Grade Serous Ovarian Cancer Prognosis and Characterization

SIMPLE SUMMARY: New therapeutical strategies are needed to improve survival in high-grade serous ovarian cancer (HGSOC) patients. AKT inhibitors are promising agents able to act in synergy with PARP inhibitors and platinum-based therapies, but the subset of patients who could benefit from this appro...

Descripción completa

Detalles Bibliográficos
Autores principales: Azzalini, Eros, Tierno, Domenico, Bartoletti, Michele, Barbazza, Renzo, Giorda, Giorgio, Puglisi, Fabio, Cecere, Sabrina Chiara, Losito, Nunzia Simona, Russo, Daniela, Stanta, Giorgio, Canzonieri, Vincenzo, Bonin, Serena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773580/
https://www.ncbi.nlm.nih.gov/pubmed/35053468
http://dx.doi.org/10.3390/cancers14020304

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773580/
https://www.ncbi.nlm.nih.gov/pubmed/35053468
http://dx.doi.org/10.3390/cancers14020304

Ejemplares similares